Inflammatory- and immune responses in relation to bacterial replication in mice following re-infections with Chlamydophila pneumoniae

Inflammation Research

Volumn 57, Issue 6, 2008, Pages 287-295

  Kis, Z ^a   Burian, K ^b   Treso, B ^a   Acs, K ^a,b   Prohaszka, Z ^c   Fust, G ^c   Gonczol, E ^a   Endresz, V ^b  

^a NATIONAL CENTER FOR EPIDEMIOLOGY   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

C. Pneumoniae; Histamine; Immune response; Re infections

Indexed keywords

GAMMA INTERFERON; HISTAMINE; INTERLEUKIN 6;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CHLAMYDOPHILA INFECTION; CHLAMYDOPHILA PNEUMONIAE; FEMALE; GENETICS; IMMUNOLOGY; LUNG; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; SPLEEN;

ANIMALS; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; FEMALE; HISTAMINE; INTERFERON-GAMMA; INTERLEUKIN-6; LUNG; MICE; MICE, INBRED BALB C; SPLEEN;

EID: 58149116668     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-007-7124-0     Document Type: Article

References (36)

1. Kuo CC, Jackson LA, Campbell LA, Grayston JT. Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 1995; 8: 451-61.
2. Campbell LA, Kuo CC. Chlamydia pneumoniae - an infectious risk factor for atherosclerosis? Nat Rev Microbiol 2004; 2: 23-32. (Pubitemid 39490045)
3. Hahn DL. Chlamydia pneumoniae, asthma, and COPD: what is the evidence? Ann Allergy Asthma Immunol 1999; 83: 271-92.
4. Martin RJ. Infections and asthma. Clin Chest Med. 2006; 27: 87-98.
5. Annagur A, Kendirli SG, Yilmaz M, Altintas DU, Inal A. Is There Any Relationship Between Asthma and Asthma Attack in Children and Atypical Bacterial Infections; Chlamydia Pneumoniae, Mycoplasma Pneumoniae and Helicobacter Pylori. J Trop Pediatr 2007; 53: 313-8. (Pubitemid 350120324)
6. Lieberman D, Lieberman D, Printz S, Ben-Yaakov M, Lazarovich Z, Ohana B et al. Atypical pathogen infection in adults with acute exacerbation of bronchial asthma. Am J Respir Crit Care Med 2003; 167: 406-10. (Pubitemid 36216424)
7. Gieffers J, Füllgraf H, Jahn J, Klinger M, Dalhoff K, Katus HA et al: Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment. Circulation 2001; 103: 351-6. (Pubitemid 32105972)
8. Campbell LA, O'Brien ER, Cappuccio AL, Kuo CC, Wang SP, Stewart D et al. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis 1995; 172: 585-8.
9. Smieja M, Mahony J, Petrich A, Boman J, Chernesky M. Association of circulating Chlamydia pneumoniae DNA with cardiovascular disease: a systematic review. BMC Infect Dis 2002; 2: 21.
10. Burián K, Hegyesi H, Buzás E, Endrész V, Kis Z, Falus A, Gönczöl E: Chlamydophila (Chlamydia) pneumoniae induces histidine decarboxylase production in the mouse lung. Immunol Lett 2003; 89: 229-36.
11. Virok D, Kis Z, Karai L, Intzedy L, K. Burian K, Szabo A et al. Chlamydia pneumoniae in atherosclerotic middle cerebral artery. Stroke 2001; 32: 1973-6. (Pubitemid 32868082)
12. Penttilä JM, Anttila M, Puolakkainen M, Laurila A, Varkila K, Sarvas M et al. Local immune responses to Chlamydia pneumoniae in the lungs of BALB/c mice during primary infection and reinfection. Infect Immun 1998; 66: 5113-8. (Pubitemid 29044598)
13. Moazed TC, Kuo CC, Grayston JT, Campbell LA. Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. J Infect Dis 1998; 177: 1322-5. (Pubitemid 28194273)
14. Erkkilä L, Laitinen K, Haasio K, Tiirola T, Jauhiainen M, Lehr HA et al. Heat shock protein 60 autoimmunity and early lipid lesions in cholesterol-fed C57BL/6JBom mice during Chlamydia pneumoniae infection. Atherosclerosis 2004; 177: 321-8. (Pubitemid 39505264)
15. Erkkilä L, Laitinen K, Laurila A, Saikku P, Leinonen M. Experimental Chlamydia pneumoniae infection in NIH/S mice: effect of reinoculation with chlamydial or cell preparation on culture, PCR and histological findings of lung tissue. Vaccine 2002; 20: 2318-24. (Pubitemid 34497042)
16. Bin XX, Wolf K, Schaffner T, Malinverni R. Effect of azithromycin plus rifampin versus amoxicillin alone on eradication and inflammation in the chronic course of Chlamydia pneumoniae pneumonitis in mice. Antimicrob Agents Chemother 2000; 44: 1761-4. (Pubitemid 30340837)
17. Campbell LA, Nosaka T, Rosenfeld ME, Yaraei K, Kuo CC. Tumor necrosis factor alpha plays a role in the acceleration of atherosclerosis by Chlamydia pneumoniae in mice. Inf Immun 2005; 73: 3164-5. (Pubitemid 40570388)
18. Kaukoranta-Tolvanen SE, Laurila AL, Saikku P, Leinonen M, Laitinen K. Experimental Chlamydia pneumoniae infection in mice: effect of reinfection and passive immunization. Microb Pathog 1995; 18: 279-88.
19. Moazed TC, Kuo CC, Grayston JT, Campbell LA. Murine models of Chlamydia pneumoniae infection and atherosclerosis. J Infect Dis 1997; 175: 883-90. (Pubitemid 27142963)
20. Yang ZP, Kuo CC, Grayston JT. A mouse model of Chlamydia pneumoniae strain TWAR pneumonitis. Infect Immun 1993; 61: 2037-40. (Pubitemid 23145910)
21. Yang ZP, Cummings PK, Patton DL, Kuo CC. Ultrastructural lung pathology of experimental Chlamydia pneumoniae pneumonitis in mice. J Infect Dis 1994; 170: 464-7. (Pubitemid 24226384)
22. Mygind T, Vandahl B, Pedersen AS, Christiansen G, Hollsberg P, Birkelund S. Identification of an in vivo CD4+ T cell-mediated response to polymorphic membrane proteins of Chlamydia pneumoniae during experimental infection. FEMS Immunol Med Microbiol 2004; 40: 129-37. (Pubitemid 38249537)
23. Paldanius M, Bloigu A, Alho M, Leinonen M, Saikku P. Prevalence and persistence of Chlamydia pneumoniae antibodies in healthy laboratory personnel in Finland. Clin Diagn Lab Immunol 2005; 12: 654-9. (Pubitemid 41184727)
24. Thom DH, Grayston JT, Campbell LA, Kuo CC, Diwan VK, Wang SP. Respiratory infection with Chlamydia pneumoniae in middle-aged and older adult outpatients. Eur J Clin Microbiol Infect Dis 1994; 13: 785-92. (Pubitemid 24359433)
25. File TM, Tan JST. Chlamydia pneumoniae pneumonia. Sem Resp Crit Care Med 2000; 21: 285-94. (Pubitemid 30661095)
26. Yang ZP, Kuo CC, Grayston JT. Systemic dissemination of Chlamydia pneumoniae following intranasal inoculation in mice. J Infect Dis 1995; 171: 736-8.
27. Ikejima H, Friedman H, Leparc GF, Yamamoto Y. Depletion of resident Chlamydia pneumoniae through leukoreduction by filtration of blood for transfusion. J Clin Microbiol 2005; 43: 4580-4. (Pubitemid 41298246)
28. Geng Y, Berencsi K, Gyulai Z, Valyi-Nagy T, Gonczol E, Trinchieri G. Roles of interleukin-12 and gamma interferon in murine Chlamydia pneumoniae infection. Infect Immun 2000; 68: 2245-53. (Pubitemid 30164861)
29. Xu X, Zhang D, Zhang H, Wolters PJ, Killeen NP, Sullivan BM et al. Neutrophil histamine contributes to inflammation in mycoplasma pneumonia. J Exp Med 2006; 203: 2907-17. (Pubitemid 46026168)
30. Monno R, De Vito D, Losito G, Sibilio G, Costi A, Fumarola L. Chlamydia pneumoniae in community-acquired pneumonia: seven years of experience. J Infect 2002; 45: 135-8. (Pubitemid 36104834)
31. Falck G, Gnarpe J, Hansson LO, Svärdsudd K, Gnarpe H. Comparison of individuals with and without specific IgA antibodies to Chlamydia pneumoniae : respiratory morbidity and the metabolic syndrome. Chest 2002; 122: 1587-93. (Pubitemid 35366068)
32. Anzini A, Cassone M, Rasura M, Ciervo A, Beccia M, Di Lisi F et al. Chlamydia pneumoniae infection in young stroke patients: a case - control study. Eur J Neurol 2004; 11: 321-7. (Pubitemid 38903565)
33. LaBiche R, Koziol D, Quinn T C, Gaydos C, Azhar S, Ketron G et al. Presence of Chlamydia pneumoniae in human symptomatic and asymptomatic carotid atherosclerotic plaque. Stroke 2001; 32: 855-60. (Pubitemid 32285148)
34. von Hertzen L, Leinonen M, Surcel HM, Karjalainen J, Saikku P. Measurement of sputum antibodies in the diagnosis of acute and chronic respiratory infections associated with Chlamydia pneumoniae. Clin Diagn Lab Immunol 1995; 2: 454-7.
35. Swanborg RH, Boros DL, Whittum-Hudson JA, Hudson AP. Molecular mimicry and horror autotoxicus: do chlamydial infections elicit autoimmunity? Expert Rev Mol Med 2006; 8: 1-23. (Pubitemid 44848624)
36. Burian K, Kis Z, Virok D, Endresz V, Prohaszka Z, Duba J et al. E: Independent and joint effects of antibodies to human heat-shock protein 60 and Chlamydia pneumoniae infection in the development of coronary atherosclerosis. Circulation 2001; 103: 1503-8. (Pubitemid 32226256)